288535
Racial and age disparities in HPV vaccine uptake in college women
Objective. To determine HPV vaccination rates and assess for age-racial disparities in uptake among college women.
Methods. A convenience sample of 1030 women (51%White; mean age 22) recruited from the University of Florida completed a questionnaire in 2011. Bivariate and multivariate analyses adjusted for race and age were performed.
Results. Approximately half (49%) of the sample was vaccinated (received 1-3 shots), and 34% completed all 3 shots. Completing all 3 shots differed by race (40% White; 35% Hispanic, 30% Asian; 18% Black and 33% other; p< 0.05). History of any STDs and Pap testing were not significantly associated with vaccination. In multivariate analysis women were more likely to be vaccinated if they were younger (18-26yrs vs. 27+), (OR=5.7, 95% CI: 3.5-9.4); and whites were more likely to be vaccinated than blacks, (OR=1.9, 95% CI: 1.3-2.8).
Conclusion. We found that only one-third of this educated sample had completed all 3 shots of the recommended HPV vaccine. We found disparities in vaccine uptake with age and race. Strategies for HPV vaccine uptake among college populations should direct efforts toward minority women.
Learning Areas:
Administer health education strategies, interventions and programsEpidemiology
Public health or related education
Social and behavioral sciences
Learning Objectives:
Describe the uptake of the human papillomavirus vaccine (HPV) in a sample of college students
Evaluate variation in human papillomavirus vaccine uptake by age and race in a sample of college students
Keyword(s): Disease Prevention, College Students
Qualified on the content I am responsible for because: I have a strong background in health behavior/education, and epidemiology. I also have multiple experience in research that inlvolved assessing health program needs and health promotion/interventions.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.